Servier (Tianjin) Pharmaceutical Co., Ltd.
Servier (Tianjin) Pharmaceutical Co., Ltd., registered and established in June 2000, is a joint venture between Servier of France and Tianjin Huajin Pharmaceutical Co., Ltd. Since its opening in 2002, the Company has maintained a good sustainable development: in 2008, the new warehouse was expanded and put into use; in 2014, the new QC laboratory building was completed and put into use; in 2016, the factory obtained the production license for the anti-cancer clinical drug trial production workshop; at the beginning of 2018, additional registered capital of EUR 10 million was invested; In 2018, the construction of its new preparation workshop was commenced, which was completed in 2020 and can be used for the production of anti-tumor drugs.